HomeSNTI • NASDAQ
Senti Biosciences Inc
add
$3.84
7.87%
After Hours:(3.91%)-0.15
$3.69
Closed: Jun 6, 5:44:32 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.23M | -13.79% |
Net income | -14.11M | -16.52% |
Net profit margin | — | — |
Earnings per share | -1.41 | — |
EBITDA | -13.58M | 1.99% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.88M | 42.24% |
Total assets | 82.78M | -18.99% |
Total liabilities | 44.92M | -2.54% |
Total equity | 37.86M | — |
Shares outstanding | 26.08M | — |
Price to book | 2.44 | — |
Return on assets | -40.16% | — |
Return on capital | -46.88% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -14.11M | -16.52% |
Cash from operations | -14.05M | -20.27% |
Cash from investing | — | — |
Cash from financing | -414.00K | — |
Net change in cash | -14.46M | -23.66% |
Free cash flow | -10.41M | -51.25% |
Previous close
$3.56
Day range
$3.30 - $3.88
Year range
$1.52 - $16.94
Market cap
100.15M USD
Avg Volume
160.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
34
